CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-16 | Rodgers Richard J Director | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2015-09-16 | Cheong Kwang Soo Director | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2015-09-16 | CARTHY MARK Director | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2015-09-16 | Brandt Peter C. Director | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2015-09-16 | Beever Charles Director | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2015-02-02 | Benaim Ely Chief Medical Officer | Grant or award · Stock Option (right to buy) | +1,200,000 | 1,200,000 | ||
| 2015-01-23 | Suzdak Peter David Chief Executive Officer | Grant or award · Stock Option (right to purchase) | +1,100,000 | 1,100,000 | ||
| 2015-01-23 | Jeong Tae Heum Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +333,332 | 333,332 | ||
| 2015-01-23 | Ahn Chang Ho Director | Grant or award · Stock Option (right to purchase) | +333,332 | 333,332 | ||
| 2015-01-12 | Jeong Tae Heum Chief Financial Officer | Exercise or conversion | +49,800 | $0.80 | $40K | 554,800 |
| 2015-01-12 | Jeong Tae Heum Chief Financial Officer | Sale | −49,800 | $0.91 | $45K | 505,000 |
| 2015-01-12 | Jeong Tae Heum Chief Financial Officer | Exercise or conversion · Stock Option (right to purchase) | −49,800 | 182,728 | ||
| 2015-01-12 | Ahn Chang Ho Director | Exercise or conversion | +48,444 | $0.80 | $39K | 6,058,444 |
| 2015-01-12 | Ahn Chang Ho Director | Sale | −48,444 | $0.91 | $44K | 6,010,000 |
| 2015-01-12 | Ahn Chang Ho Director | Exercise or conversion · Stock Option (right to purchase) | −48,444 | 549,151 | ||
| 2015-01-09 | Jeong Tae Heum Chief Financial Officer | Exercise or conversion | +188,690 | $0.80 | $151K | 693,690 |
| 2015-01-09 | Jeong Tae Heum Chief Financial Officer | Sale | −188,690 | $0.92 | $173K | 505,000 |
| 2015-01-09 | Jeong Tae Heum Chief Financial Officer | Exercise or conversion · Stock Option (right to purchase) | −188,690 | 232,528 | ||
| 2015-01-09 | Ahn Chang Ho Director | Exercise or conversion | +186,212 | $0.80 | $149K | 6,196,212 |
| 2015-01-09 | Ahn Chang Ho Director | Sale | −186,212 | $0.92 | $170K | 6,010,000 |
Page 18 of 22 · 437 trades